| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/13/2002 | EP1178821A1 Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 02/13/2002 | EP1178817A2 Molecular interactions in haematopoietic cells |
| 02/13/2002 | EP1178815A1 Death domain containing receptors |
| 02/13/2002 | EP1178801A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 02/13/2002 | EP1178797A1 Inhibitors of impdh enzyme |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP0769957B1 Methods for treating motor deficits |
| 02/13/2002 | EP0630257B1 Thymus-derived, immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335766A A process for the preparation of suspensions of drug particles for inhalation delivery |
| 02/13/2002 | CN1335161A Deer bone powder capsule |
| 02/12/2002 | US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346602 Peptide mimics of the cytokine receptor common γ chain and methods and compositions for making and using the same |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346247 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/12/2002 | CA2110273C Benzimidazole derivatives, their preparation process and their use in the fields of therapeutics and cosmetics |
| 02/12/2002 | CA2097317C Antiallergic piperdinyl benzimidazoles |
| 02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
| 02/12/2002 | CA2067877C Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present |
| 02/11/2002 | CA2740282A1 Purification of hbv antigens for use in vaccines |
| 02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
| 02/07/2002 | WO2002010410A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010369A1 Tumor antigen |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010211A1 A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010191A2 Immunomodulatory compounds |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010136A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2002010115A1 New processes for the production of fexofenadine |
| 02/07/2002 | WO2002009793A1 Device for treating immune diseases |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |
| 02/07/2002 | WO2002009762A2 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009752A2 Immunological adjuvant compounds |
| 02/07/2002 | WO2002009751A2 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF |
| 02/07/2002 | WO2002009748A1 Innate immune system-directed vaccines |
| 02/07/2002 | WO2002009747A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/07/2002 | WO2002009746A2 Vaccines comprising outer membrane vesciles from gram negative bacteria |
| 02/07/2002 | WO2002009744A2 Modified sialic acid vaccines |
| 02/07/2002 | WO2002009718A2 Agents containing corticosteroids for reducing graft rejection reactions |
| 02/07/2002 | WO2002009699A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 02/07/2002 | WO2002009681A2 A method for correcting the immune system of live body |
| 02/07/2002 | WO2002009674A2 Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2001078652A3 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/07/2002 | WO2001074811A3 Substituted 1,3-thiazole compounds, their production and use |
| 02/07/2002 | WO2001062911A3 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001043770A3 Method for enhancing immune responses in mammals |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001040240A3 Mono- and disaccharide derivatives |
| 02/07/2002 | WO2001036448A3 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001032841A3 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 02/07/2002 | WO2001030333A3 Tissue factor antagonists and methods of use thereof |
| 02/07/2002 | WO2001025415A3 Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 02/07/2002 | US20020016471 Inhibitors of p38 |
| 02/07/2002 | US20020016467 Novel 4-diphenylmethyl piperdine derivatives |
| 02/07/2002 | US20020016370 A therapeutically effective amount of exo-R-mecamylamine or salt, substantially free of exo-S-mecamylamine in combination with a carrier; useful for treating substance addiction |
| 02/07/2002 | US20020016362 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 02/07/2002 | US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 02/07/2002 | US20020016354 Treatment of respiratory diseases, convulsions, vascular disorders, renal disorders, urinary disorders, Alzheimer's disease, dysmenorrhea, narcolepsy |
| 02/07/2002 | US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha |
| 02/07/2002 | US20020016336 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis or invasion, periodontal disease and bone disease |
| 02/07/2002 | US20020016328 Corticotropin releasing factor antagonists |
| 02/07/2002 | US20020016321 Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/07/2002 | US20020016315 Metered unit dose comprising 40 mu g or less of budesonide is disclosed as well as a formulation thereof and the use for the treatment of conditions in the nose, especially rhinitis. |
| 02/07/2002 | US20020016313 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 02/07/2002 | US20020016292 Pharmaceutical compositions containing cyclosporins |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015957 Detecting in a biological sample from the subject an abnormal activity or an abnormal level of at least one complement pathway associated molecule, or an abnormal cellular activity mediated by the complement pathway |
| 02/07/2002 | US20020015745 Process for enhancing immune response in canines using a dietary composition including garlic |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |